Pharmacogenomics: Tailoring drug therapies for improved outcomes
While research from as far back as the 1960's indicates that genetic variations are directly responsible for different medication responses, only recently have the reduced costs of testing made the benefits of pharmacogenomics (PGx) available to many patients. While the list of clinical trials and PGx tests is continually expanding, many medications are not yet associated with clinically useful guidance.
You may also like:
Recently, I participated in the annual meeting of one of my favorite organizations: The American Society of Automation in Pharmacy (ASAP). ASAP's mission is to foster ...
An outbreak of coronavirus in Wuhan, China, has captured international attention, killing 82 in China (as of January 27 reports)...
Filter by Type
Sign up to receive the latest news and information!